Update (September 2): The CDC greenlighted the use of the Moderna and Pfizer Omicron boosters yesterday, meaning that the shots could start being administered within days. People must have had their ...

Meanwhile, Moderna CEO Stéphane Bancel told CNBC it is currently working on an Omicron-specific shot that is about to start clinical testing and could be available in the autumn.

The UK has become the first country in the world to authorise an updated COVID-19 booster vaccine directed at the Omicron variant, giving a green light to Moderna's mRNA-1273.214 shot.

Moderna Inc. said Thursday a Phase 3 trial of ... which showed that mRNA-1283 had higher neutralizing antibody responses against both Omicron BA.4/5 and ancestral SARS-CoV-2 than mRNA-1273 ...

Moderna Inc. announced Tuesday that its next ... as it demonstrated a higher immune response against the Omicron BA.4/BA.5 and original virus strains of COVID-19, when compared with its Spikevax ...

1 Omicron subvariant, which was prevalent last winter, and the original novel coronavirus strain that the previous vaccines were designed to fight. Pfizer Inc. and Moderna Inc. have each applied ...

a subvariant of the Omicron strain that includes EG.5 and BA.2.86. The vaccine, developed by Moderna Inc., will be administered from Sept.